Compounds having beta adrenergic receptor agonist and muscarinic receptor antagonist activity
申请人:Mammen Mathai
公开号:US20060035933A1
公开(公告)日:2006-02-16
This invention provides compounds of formula I:
wherein R
1
, R
2
, R
4
, R
5
, R
6
, R
7
, R
8a
, R
8b
, W, a, b, c and m are as defined in the specification, or a pharmaceutically acceptable salt or solvate or stereoisomer thereof. The compounds of this invention possess both β
2
adrenergic receptor agonist and muscarinic receptor antagonist activity. Accordingly, such compounds are expected to be useful as therapeutic agents for treating pulmonary disorders, such as chronic obstructive pulmonary disease and asthma.
这项发明提供了式I的化合物:其中R1、R2、R4、R5、R6、R7、R8a、R8b、W、a、b、c和m如规范中所定义,或其药学上可接受的盐、溶剂或立体异构体。本发明的化合物具有β2肾上腺素受体激动剂和肌碱受体拮抗剂活性。因此,这些化合物预计可用作治疗肺部疾病,如慢性阻塞性肺病和哮喘的治疗剂。